Ferric Derisomaltose Generics

Form: IV Infusion

Strength: 200 mg/ml

Reference Brands: Monoferric® (U.S.) and Monofer® (EU))

Category: Anemia

Ferric Derisomaltose, marketed as Monoferric® in the U.S. and Monofer® in the EU, is a next-generation intravenous iron therapy used for treating iron deficiency anemia in adults, particularly when oral iron is ineffective or not tolerated. Its high-concentration formulation (200 mg/mL) allows for single high-dose administration, improving patient compliance and reducing treatment time. In the pharmaceutical B2B market, Ferric Derisomaltose is in high demand across hospitals, dialysis centers, and specialty clinics. In both the U.S. and EU, it is supplied under GMP conditions for institutional supply, private labeling, and international distribution through licensed manufacturers and contract partners